Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages.
about
Hallmarks of cancer and AU-rich elementsEstablishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation.The Fragment HMGA2-sh-3p20 from HMGA2 mRNA 3'UTR Promotes the Growth of Hepatoma Cells by Upregulating HMGA2.Regulation of the mRNA half-life in breast cancerTristetraprolin represses estrogen receptor α transactivation in breast cancer cellsTRIM24 links glucose metabolism with transformation of human mammary epithelial cellsPoly(ADP-ribose) polymerase-13 and RNA regulation in immunity and cancer.Baseline blood immunological profiling differentiates between Her2-breast cancer molecular subtypes: implications for immunomediated mechanisms of treatment response.Genetic variants in microRNA target sites of 37 selected cancer-related genes and the risk of cervical cancer.Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function.Regulation of cellular processes by interleukin-16 in homeostasis and cancer.Post-transcriptional control of cytokine gene expression in health and disease.Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.Post-transcriptional regulation of cytokine and growth factor signaling in cancer.Neutrophil-Derived Interleukin 16 in Premetastatic Lungs Promotes Breast Tumor Cell Seeding.The role of RNA-binding protein tristetraprolin in cancer and immunity.The RNA-binding protein HuR inhibits expression of CCL5 and limits recruitment of macrophages into tumors.Killing Is Not Enough: How Apoptosis Hijacks Tumor-Associated Macrophages to Promote Cancer Progression.PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis.
P2860
Q26744134-8B3D843E-75F1-49FE-AE16-52CE576375ABQ33572502-24A4C64A-2BFC-4E56-ABBB-F3147ACB31B3Q33704649-E58FA16D-D221-4CDC-BE5E-40C38012EC42Q34023658-8849D149-0E7F-465A-8AB4-4D6268A525E6Q34075981-14C105B9-D481-4655-9D26-D1810BD4F753Q35209056-133DDE28-8D1D-4F61-8107-626E927DC622Q35691217-AD5C0F21-CD69-4EC3-98D3-25AD0A9D79FFQ36307206-563597CF-B2F0-40FF-8BCB-A417774CFC1BQ37505341-6E143944-0356-4ECF-A207-9308532808CBQ37686167-A85F1B74-D723-4930-94E8-F9CCA61FED20Q38124813-3D5D10AF-1FA4-4CC8-8B81-3AAF592890A0Q38623564-3724D8AD-70F9-4645-BAC2-309187BECA22Q38756385-6D63EC9B-5105-44C7-BB7C-489FC3258E4CQ39036700-8D274307-059A-4F3E-94F8-F219D8FACA86Q47159534-B314CBC7-2CA5-4B17-B689-5276F6CC5EC5Q47417882-2A95E013-FF70-4213-9D75-0BA7DCF6266FQ48088391-BE2DF163-34BB-4DBD-A04D-D43C4B13CFAEQ51551641-2AD12C85-03A8-43E4-8A37-8D6DCE2770E9Q52344482-8BB9484D-D430-4F3F-A54D-9B189104B079
P2860
Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Depletion of tristetraprolin i ...... on with monocytes/macrophages.
@en
Depletion of tristetraprolin i ...... on with monocytes/macrophages.
@nl
type
label
Depletion of tristetraprolin i ...... on with monocytes/macrophages.
@en
Depletion of tristetraprolin i ...... on with monocytes/macrophages.
@nl
prefLabel
Depletion of tristetraprolin i ...... on with monocytes/macrophages.
@en
Depletion of tristetraprolin i ...... on with monocytes/macrophages.
@nl
P2093
P2860
P356
P1433
P1476
Depletion of tristetraprolin i ...... on with monocytes/macrophages.
@en
P2093
Andreas Weigert
Kathrin Schulz
Larissa Milke
Tobias Schmid
Weixiao Sha
P2860
P304
P356
10.1093/CARCIN/BGS387
P407
P577
2012-12-14T00:00:00Z